In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Embecta Corp’s current price at $6.27 is substantially below the PERT-weighted fair value of $33.59, indicating significant undervaluation with high confidence. Monte Carlo analysis shows zero downside risk below the current price and expected values exceeding $40, despite high volatility (43.33% coefficient of variation). Strong liquidity and growth contrast with zero profitability, signaling high opportunity with elevated risk.